- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Towards a new tuberculosis drug: pyridomycin – nature's isoniazid ; volume:4 ; number:10 ; year:2012 ; pages:1032-1042 ; extent:11
EMBO molecular medicine / European Molecular Biology Organization ; 4, Heft 10 (2012), 1032-1042 (gesamt 11)
- Creator
-
Hartkoorn, Ruben C.
Sala, Claudia
Neres, João
Pojer, Florence
Magnet, Sophie
Mukherjee, Raju
Uplekar, Swapna
Boy‐Röttger, Stefanie
Altmann, Karl‐Heinz
Cole, Stewart T.
- DOI
-
10.1002/emmm.201201689
- URN
-
urn:nbn:de:101:1-2023022406565210096815
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hartkoorn, Ruben C.
- Sala, Claudia
- Neres, João
- Pojer, Florence
- Magnet, Sophie
- Mukherjee, Raju
- Uplekar, Swapna
- Boy‐Röttger, Stefanie
- Altmann, Karl‐Heinz
- Cole, Stewart T.
Other Objects (12)
Treatment of isoniazid-resistant pulmonary tuberculosis
Tetrandrine reverses drug resistance in isoniazid and ethambutol dual drug-resistant Mycobacterium tuberculosis clinical isolates
Isoniazid-specific T-cell Responses in patients with anti-tuberculosis drug related liver injury
3D-Printed Isoniazid Tablets for the Treatment and Prevention of Tuberculosis—Personalized Dosing and Drug Release
Sustained release of isoniazid from polylactide microspheres prepared using solid/oil drug loading method for tuberculosis treatment
Real-life isoniazid and rifampicin plasma concentrations in children: a tool for therapeutic drug monitoring of tuberculosis
Treatment outcomes of retreated patients with isoniazid/rifampicin resistant pulmonary tuberculosis
Precision Medicine Strategies to Improve Isoniazid Therapy in Patients with Tuberculosis
Cost-effectiveness of 3-months isoniazid and rifapentine compared to 9-months isoniazid for latent tuberculosis infection: a systematic review
Isoniazid-Induced Psychosis in a Patient with Pulmonary Tuberculosis: A Case Report
Eigenschaften Isoniazid-resistenter Mycobacterium tuberculosis Stämme unter besonderer Berücksichtigung des Sauerstoffverbrauches als Virulenzkriterium
The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis
Treatment of isoniazid-resistant pulmonary tuberculosis
Tetrandrine reverses drug resistance in isoniazid and ethambutol dual drug-resistant Mycobacterium tuberculosis clinical isolates
Isoniazid-specific T-cell Responses in patients with anti-tuberculosis drug related liver injury
3D-Printed Isoniazid Tablets for the Treatment and Prevention of Tuberculosis—Personalized Dosing and Drug Release
Sustained release of isoniazid from polylactide microspheres prepared using solid/oil drug loading method for tuberculosis treatment
Real-life isoniazid and rifampicin plasma concentrations in children: a tool for therapeutic drug monitoring of tuberculosis
Treatment outcomes of retreated patients with isoniazid/rifampicin resistant pulmonary tuberculosis
Precision Medicine Strategies to Improve Isoniazid Therapy in Patients with Tuberculosis
Cost-effectiveness of 3-months isoniazid and rifapentine compared to 9-months isoniazid for latent tuberculosis infection: a systematic review
Isoniazid-Induced Psychosis in a Patient with Pulmonary Tuberculosis: A Case Report
Eigenschaften Isoniazid-resistenter Mycobacterium tuberculosis Stämme unter besonderer Berücksichtigung des Sauerstoffverbrauches als Virulenzkriterium
The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis
Treatment of isoniazid-resistant pulmonary tuberculosis
Tetrandrine reverses drug resistance in isoniazid and ethambutol dual drug-resistant Mycobacterium tuberculosis clinical isolates
Isoniazid-specific T-cell Responses in patients with anti-tuberculosis drug related liver injury
3D-Printed Isoniazid Tablets for the Treatment and Prevention of Tuberculosis—Personalized Dosing and Drug Release
Sustained release of isoniazid from polylactide microspheres prepared using solid/oil drug loading method for tuberculosis treatment
Real-life isoniazid and rifampicin plasma concentrations in children: a tool for therapeutic drug monitoring of tuberculosis
Treatment outcomes of retreated patients with isoniazid/rifampicin resistant pulmonary tuberculosis
Precision Medicine Strategies to Improve Isoniazid Therapy in Patients with Tuberculosis
Cost-effectiveness of 3-months isoniazid and rifapentine compared to 9-months isoniazid for latent tuberculosis infection: a systematic review
Isoniazid-Induced Psychosis in a Patient with Pulmonary Tuberculosis: A Case Report
Eigenschaften Isoniazid-resistenter Mycobacterium tuberculosis Stämme unter besonderer Berücksichtigung des Sauerstoffverbrauches als Virulenzkriterium